Semble

Investor: Revaia

Semble, a prominent health technology company, has successfully secured a £30 million Series C funding round. This significant investment is earmarked to propel the expansion of its innovative healthcare management platform, specifically targeting outpatient providers across the UK and Europe.Summary of transaction details:Value: £30,000,000 GBPSector: Healthcare & BiotechAdvisor: Not specifiedKey Entities: Target Company: Semble; Lead Investor: Revaia; Participating Investors: Partech, Mercia Ventures, Octopus VenturesLocation: UK and Europe (for expansion)Note: The funding round will enable Semble to scale its operations, enhance its AI orchestration capabilities, and strengthen its market presence in France, addressing the critical need for integrated and patient-centred care solutions amidst growing operational challenges in the healthcare sector.